Much evidence has been gathered in support of a critical role for p53
in the cellular response to DNA damage. p53 dysfunction is associated
with progression and poor prognosis of many human cancers and with a h
igh incidence of tumours in p53 knockout mice. The absence of a p53-de
pendent G(1) arrest that facilitates DNA repair or apoptosis might imp
act critically on clinical cancer in two ways. First, by abrogating th
e impact on therapy that operates via genotoxic damage and apoptosis;
and second, by encouraging progression either by inducing genomic inst
ability and DNA mis-repair or by permitting survival of mutants. Howev
er, experiments examining the relationship between p53 deficiency and
mutation frequency have so far failed to confirm these predictions. Th
e precise role played by p53 is therefore unclear. We now report use o
f a short term in vitro approach to assess the influence of p53 on rad
iation-induced mutations at the hprt locus in murine B cell precursors
that are normally radiation ultrasensitive, We find a high number of
hprt mutants among X-irradiated p53 null cells, which results from pre
ferential survival as clonogenic mutants rather than from a p53-depend
ent increase in mutation rate. This result has important implications
for genotoxic cancer therapy.